# Insmed

**Canonical:** https://apis.io/providers/insmed/  
**Website:** https://www.insmed.com/  
**APIs profiled:** 0

Insmed Incorporated is a NASDAQ-listed (INSM) global biopharmaceutical company developing and commercializing therapies for people with serious and rare diseases. Its approved medicines include ARIKAYCE (amikacin liposome inhalation suspension) for refractory Mycobacterium avium complex lung disease and BRINSUPRI (brensocatib) for bronchiectasis. The company advances a pipeline across pulmonary, inflammatory, and rare-disease indications and runs early-innovation science platforms in gene therapy with targeted delivery, protein deimmunization, RNA end-joining, and synthetic rescue. Insmed operates patient-facing surfaces such as a clinical-trials portal and an investigator-initiated-research program, but publishes no public developer API, OpenAPI, or developer portal at this time. This profile was surfaced as a Bessemer Venture Partners portfolio lead and enriched with identity and domain-security data only.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Insmed Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotech, Biopharmaceutical, Pharmaceuticals, Healthcare, Rare Disease, Clinical Trials, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/insmed/). Scores are computed from the provider's own public artifacts under a published rubric.